PKIB and urinary bladder carcinoma: In conclusion, our data suggest that high expression of PKIB, regulated by MYCN, mediates reduced HSP27 phosphorylation through inhibition of PKA kinase activity, thereby inducing a malignant phenotype in human bladder cancer (Fig. 7L).